Most cited papers from SLA Pharma (United Kingdom)
What are the most cited papers from SLA Pharma (United Kingdom)?
The most cited paper from SLA Pharma (United Kingdom) is "Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer" (A.S.T. Planting, Gilles Catimel, Pieter H. M. De Mulder et al., 1999), with 99 citations. Next come "Reversal of Opioid‐Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone" (18) and "Development and validation of a chiral high-performance liquid chromatography assay for rogletimide and rogletimide- N -oxide isomers in plasma" (1).
Showing 3 of 3 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer A.S.T. Planting, Gilles Catimel, Pieter H. M. De Mulder et al. · Annals of Oncology | Jun 1999 | 99 |
| 2 | Reversal of Opioid‐Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone Mark J. Ellison, Emily Hutton, Lynn Roy Webster et al. · The Journal of Clinical Pharmacology | 4 Mar 2024 | 18 |
| 3 | Development and validation of a chiral high-performance liquid chromatography assay for rogletimide and rogletimide- N -oxide isomers in plasma M C Etienne, W. Oster, Gerard A. Milano · Cancer Chemotherapy and Pharmacology | Jul 1996 | 1 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.